HCP
BMY icon

Hexagon Capital Partners’s Bristol-Myers Squibb BMY Stock Holding History

Hexagon Capital Partners’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.04M Sell
17,151
-634
-4% -$37K 0.15% 62
2025
Q4 		$959K Buy
17,785
+7
+0% +$337 0.18% 47
2025
Q3 		$802K Buy
17,778
+269
+2% +$12.6K 0.16% 52
2025
Q2 		$810K Sell
17,509
-332
-2% -$16.3K 0.18% 47
2025
Q1 		$1.09M Buy
17,841
+567
+3% +$33K 0.21% 53
2024
Q4 		$977K Buy
17,274
+1,465
+9% +$81.9K 0.18% 58
2024
Q3 		$818K Buy
15,809
+4,080
+35% +$191K 0.16% 63
2024
Q2 		$487K Sell
11,729
-3,948
-25% -$177K 0.11% 98
2024
Q1 		$850K Buy
15,677
+1,636
+12% +$83.3K 0.19% 55
2023
Q4 		$720K Buy
14,041
+3,955
+39% +$208K 0.17% 63
2023
Q3 		$585K Buy
10,086
+887
+10% +$54.3K 0.15% 69
2023
Q2 		$588K Buy
9,199
+491
+6% +$32.9K 0.16% 63
2023
Q1 		$604K Buy
8,708
+102
+1% +$7.19K 0.17% 60
2022
Q4 		$619K Sell
8,606
-1,078
-11% -$81.3K 0.18% 56
2022
Q3 		$688K Buy
9,684
+1,976
+26% +$143K 0.2% 55
2022
Q2 		$593K Sell
7,708
-462
-6% -$35.2K 0.18% 70
2022
Q1 		$597K Sell
8,170
-577
-7% -$38.7K 0.16% 74
2021
Q4 		$545K Buy
8,747
+1,991
+29% +$117K 0.14% 85
2021
Q3 		$400K Buy
6,756
+265
+4% +$17.5K 0.12% 94
2021
Q2 		$434K Buy
6,491
+641
+11% +$41.8K 0.12% 90
2021
Q1 		$369K Buy
5,850
+294
+5% +$18.3K 0.1% 87
2020
Q4 		$344K Buy
5,556
+410
+8% +$25.2K 0.1% 84
2020
Q3 		$306K Buy
+5,146
New +$310K 0.1% 90

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Hexagon Capital Partners's BMY Position: Q1 2026 in Review

Hexagon Capital Partners reduced its Bristol-Myers Squibb (BMY) stake by 3.6% in Q1 2026, selling an estimated $37K and leaving 17,151 shares worth $1.04M. The position accounts for 0.15% of the portfolio, ranked #62.

Hexagon Capital Partners first reported a position in BMY in Q3 2020 and has held it in 23 quarters since. The position peaked at $1.09M in Q1 2025. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Hexagon Capital Partners held 17,151 shares of Bristol-Myers Squibb worth $1.04M as of Q1 2026.
  • Hexagon Capital Partners sold 634 Bristol-Myers Squibb shares in Q1 2026, an estimated $37K.
  • Bristol-Myers Squibb made up 0.15% of Hexagon Capital Partners's portfolio in Q1 2026, its #62 holding.
  • Hexagon Capital Partners first reported a position in Bristol-Myers Squibb in Q3 2020 and has held it in 23 quarters since.
  • Hexagon Capital Partners's Bristol-Myers Squibb position peaked at $1.09M in Q1 2025.
  • 2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Hexagon Capital Partners's 13F filing for Q1 2026, filed 5 May 2026.